CTXR
CitiusยทNASDAQ
--
--(--)
--
--(--)
CTXR Profile
Citius Pharmaceuticals, Inc.
A late-stage biopharmaceutical company that developing and commercializing first-in-class critical care products
11 Commerce Drive, First Floor, Cranford, NJ 07016
--
Citius Pharmaceuticals, Inc., was incorporated on January 23, 2007 as Citius Pharmaceuticals, LLC, a Massachusetts limited liability company. Headquartered in Cranford, NJ, the Company is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products for critical medical needs, with a focus on anti-infective products and unique prescription products in adjuvant cancer care. The company's goal is to achieve a leading market position by providing therapeutic products that address unmet medical needs. New formulations of previously approved drugs with extensive safety and efficacy data are a core focus as companies seek to reduce development and clinical risks associated with drug development. The company's strategy centers on products with intellectual property and regulatory protection, while providing a competitive advantage over existing treatments.
